Skip to main content


Volume 5 Supplement 1

Proceedings of the Bio-Ontologies Special Interest Group 2013


Edited by Larisa N Soldatova, Philippe Rocca-Serra, Michel Dumontier, Nigam H Shah

Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. Articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.

Bio-Ontologies Special Interest Group 2013.

Berlin, Germany20 July 2013

  1. Content type: Introduction

    Over the 16 years, the Bio-Ontologies SIG at ISMB has provided a forum for vibrant discussions of the latest and most innovative advances in the research area of bio-ontologies, its applications to biomedicine...

    Authors: Larisa N Soldatova, Philippe Rocca-Serra, Michel Dumontier and Nigam H Shah

    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):I1

    Published on:

  2. Content type: Proceedings

    Accounts of evidence are vital to evaluate and reproduce scientific findings and integrate data on an informed basis. Currently, such accounts are often inadequate, unstandardized and inaccessible for computat...

    Authors: Christian Bölling, Michael Weidlich and Hermann-Georg Holzhütter

    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):S1

    Published on:

  3. Content type: Proceedings

    Ontologies encode relationships within a domain in robust data structures that can be used to annotate data objects, including scientific papers, in ways that ease tasks such as search and meta-analysis. Howev...

    Authors: Chayan Chakrabarti, Thomas B Jones, George F Luger, Jiawei F Xu, Matthew D Turner, Angela R Laird and Jessica A Turner

    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):S2

    Published on:

  4. Content type: Proceedings

    With the advent of inexpensive assay technologies, there has been an unprecedented growth in genomics data as well as the number of databases in which it is stored. In these databases, sample annotation using ...

    Authors: Emily Merrill, Stéphane Corlosquet, Paolo Ciccarese, Tim Clark and Sudeshna Das

    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):S3

    Published on:

  5. Content type: Proceedings

    The molecular etiology is still to be identified for about half of the currently described Mendelian diseases in humans, thereby hindering efforts to find treatments or preventive measures. Advances, such as n...

    Authors: Anika Oellrich, Sebastian Koehler, Nicole Washington, Chris Mungall, Suzanna Lewis, Melissa Haendel, Peter N Robinson and Damian Smedley

    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):S4

    Published on:

  6. Content type: Proceedings

    The lack of established standards to describe and annotate biological assays and screening outcomes in the domain of drug and chemical probe discovery is a severe limitation to utilize public and proprietary d...

    Authors: Saminda Abeyruwan, Uma D Vempati, Hande Küçük-McGinty, Ubbo Visser, Amar Koleti, Ahsan Mir, Kunie Sakurai, Caty Chung, Joshua A Bittker, Paul A Clemons, Steve Brudz, Anosha Siripala, Arturo J Morales, Martin Romacker, David Twomey, Svetlana Bureeva…

    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):S5

    Published on:

  7. Content type: Proceedings

    Matching and comparing sequence annotations of different reference sequences is vital to genomics research, yet many annotation formats do not specify the reference sequence types or versions used. This makes ...

    Authors: Zuotian Tatum, Marco Roos, Andrew P Gibson, Peter EM Taschner, Mark Thompson, Erik A Schultes and Jeroen FJ Laros

    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):S6

    Published on:

Annual Journal Metrics